Frontlight ResearchEarly access
Trial site
Shimokitazawa Tomo Clinic
- 4running trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Obesity3 trials
- Type 2 diabetes3 trials
- Familial hypercholesterolaemia1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 33 trials
- Phase 41 trial
- Status
- Active, not recruiting3 trials
- Recruiting1 trial
- Lead sponsor
- Eli Lilly and Company3 trials
- Kowa Company, Ltd.1 trial
Running trials
Recruiting
Active, not recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Familial hypercholesterolaemia1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026